Pentraxin 3: Mean (±SD) 4.3 (1.4) pg/mL in the psoriasis group vs. 3.2 (0.9) pg/mL in the control group (p < 0.001, two-tailed; effect size = 0.17). This evidence concerns the gene PTX3 and psoriasis.